Organizer
C&EN
C&EN
Chemical & Engineering News (C&EN) is the flagship magazine of the American Chemical Society, an organization with over 157,000 members in over 100 countries. "Like" C&EN if you're a professional looking for chemistry news or are simply a chemistry fan.
Tags
Academy/Principles
LinkedIn Logo

Accelerating Drug Discovery: Enhanced Chemistry Strategies for NCEs, ADCs, and Emerging Modalities

RECORD | Already taken place We, 17.9.2025
Join Eurofins Discovery experts to explore AI-driven, high-throughput chemistry strategies accelerating novel therapeutics, from ADCs to degraders and small molecules.
Go to the webinar
C&EN: Accelerating Drug Discovery: Enhanced Chemistry Strategies for NCEs, ADCs, and Emerging Modalities
C&EN: Accelerating Drug Discovery: Enhanced Chemistry Strategies for NCEs, ADCs, and Emerging Modalities

The need for efficient and innovative drug discovery chemistry strategies to support novel modalities like Degraders, ADCs (Antibody-Drug Conjugates), and other complex therapeutics has never been greater.

In this webinar, Eurofins Discovery’s global team of chemistry experts will share how integrated, AI-enhanced workflows and high-throughput methods are accelerating the development of robust candidates. Drawing on our proven expertise in medicinal, computational, synthetic, and analytical chemistry, we’ll explore how our streamlined, automation-driven approach enables the rapid delivery of potent, high-quality compounds, while ensuring IP protection and cost efficiency.

The session will highlight real-world applications of these capabilities, including the story of an A2A receptor program that progressed from early-stage discovery to preclinical candidate nomination for Parkinson’s Disease, and was later successfully repositioned for Immuno-Oncology. We’ll also explore how our chemistry strategies are enabling the development of complex modalities such as degraders and ADCs, demonstrating the scalability and precision of our approach across diverse therapeutic platforms.

Whether you're working on traditional small molecules or next-generation biologically targeted therapies, this session will help you identify practical strategies to reduce risk, enhance translational success, and accelerate your discovery pipeline.

Key Learning Objectives:
  • Leverage integrated chemistry platforms support to accelerate iteration and decision-making across modalities, including NCEs, ADCs, and hybrids
  • Apply innovative approaches to payload-linker synthesis and conjugation in ADCs development
  • Discover advanced tools and techniques to speed up hit-to-lead transitions and lead optimization
  • Explore case studies that demonstrate successful implementation of discovery strategies
  • Enhance efficiency, reduce attrition, and improve candidate quality through streamlined chemistry workflows

Presenter: Sujay Basu, Ph.D. (Director, Discovery Chemistry, Eurofins Discovery)

Presenter: Matthew Horwitz, Ph.D. (Project Manager & Head of Scale-up Laboratory, Eurofins Discovery)

C&EN
LinkedIn Logo
 

Related content

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Metabolomics

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Environmental

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Environmental

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/HRMS, Particle characterization, LC/IT
Manufacturer
Waters
Industries
Lipidomics

Out-of-the-box workflow for PFAS quantitation using a fullscan high-resolution approach with the Orbitrap Exploris EFOX Mass Detector

Applications
| 2025 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Environmental
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike